Differential regulation of renal Klotho and FGFR1 in normal and uremic rats

FASEB J. 2017 Sep;31(9):3858-3867. doi: 10.1096/fj.201700006R. Epub 2017 May 17.

Abstract

In renal failure, hyperphosphatemia occurs despite a marked elevation in serum fibroblast growth factor (FGF)-23. Abnormal regulation of the FGFR1-Klotho receptor complex may cause a resistance to the phosphaturic action of FGF23. The purpose of the present study was to investigate the regulation of renal Klotho and FGF receptor (FEFR)-1 in healthy and uremic rats induced by 5/6 nephrectomy. In normal rats, the infusion of rat recombinant FGF23 enhanced phosphaturia and increased renal FGFR1 expression; however, Klotho expression was reduced. Uremic rats on a high-phosphate (HP) diet presented hyperphosphatemia with marked elevation of FGF23 and an increased fractional excretion of phosphate (P) that was associated with a marked reduction of Klotho expression and an increase in FGFR1. After neutralization of FGF23 by anti-FGF23 administration, phosphaturia was still abundant, Klotho expression remained low, and the FGFR1 level was reduced. These results suggest that the expression of renal Klotho is modulated by phosphaturia, whereas the FGFR1 expression is regulated by FGF23. Calcitriol (CTR) administration prevented a decrease in renal Klotho expression. In HEK293 cells HP produced nuclear translocation of β-catenin, together with a reduction in Klotho. Wnt/β-catenin inhibition with Dkk-1 prevented the P-induced down-regulation of Klotho. The addition of CTR to HP medium was able to recover Klotho expression. In summary, high FGF23 levels increase FGFR1, whereas phosphaturia decreases Klotho expression through the activation of Wnt/β-catenin pathway.-Muñoz-Castañeda, J. R., Herencia, C., Pendón-Ruiz de Mier, M. V., Rodriguez-Ortiz, M. E., Diaz-Tocados, J. M., Vergara, N., Martínez-Moreno, J. M., Salmerón, M. D., Richards, W. G., Felsenfeld, A., Kuro-O, M., Almadén, Y., Rodríguez, M. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats.

Keywords: FGF23; chronic kidney disease; mineral metabolism; phosphaturia.

MeSH terms

  • Animals
  • Calcitriol / pharmacology
  • Dietary Proteins / administration & dosage
  • Dietary Proteins / adverse effects
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / administration & dosage
  • Fibroblast Growth Factors / pharmacology
  • Gene Expression Regulation / physiology*
  • Glucuronidase / genetics
  • Glucuronidase / metabolism*
  • HEK293 Cells
  • Humans
  • Klotho Proteins
  • Male
  • Phosphates / pharmacology
  • Rats
  • Rats, Wistar
  • Receptor, Fibroblast Growth Factor, Type 1 / genetics
  • Receptor, Fibroblast Growth Factor, Type 1 / metabolism*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Renal Insufficiency / metabolism*
  • Uremia / metabolism*
  • Wnt Signaling Pathway / physiology
  • beta Catenin / genetics
  • beta Catenin / metabolism

Substances

  • CTNNB1 protein, human
  • Ctnnb1 protein, rat
  • Dietary Proteins
  • FGF23 protein, human
  • Fgf23 protein, rat
  • Phosphates
  • Recombinant Proteins
  • beta Catenin
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Fgfr1 protein, rat
  • Receptor, Fibroblast Growth Factor, Type 1
  • Glucuronidase
  • Klotho Proteins
  • Calcitriol